<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="158862">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01030744</url>
  </required_header>
  <id_info>
    <org_study_id>GDM Elasy</org_study_id>
    <nct_id>NCT01030744</nct_id>
  </id_info>
  <brief_title>Evaluation of the Gestational Diabetes Self-Management Education Program and Quality Improvement Plan</brief_title>
  <acronym>GDM Elasy</acronym>
  <official_title>Evaluation of the Gestational Diabetes Self-Management Education Program and Quality Improvement Plan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The broad, long-term objectives are to generate and test hypotheses leading to theories that
      guide improved care of patients with gestational diabetes. The purpose of this chart review
      study is to evaluate the Vanderbilt Gestational Diabetes Self-Management Education Program
      and Quality Improvement Plan in optimizing metabolic control and improving health outcomes
      during pregnancy with gestational diabetes.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    This is quality improvement review and should not have been registered.
  </why_stopped>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Self-Monitoring of Blood Glucose</measure>
    <time_frame>chart review quarterly during course of study</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Gestational Diabetes</condition>
  <arm_group>
    <arm_group_label>Gestational Diabetes</arm_group_label>
    <description>Women with gestational diabetes who are referred to and followed in the Vanderbilt Eskind Diabetes Clinic and are participants in the gestational diabetes educational program.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Women with gestational diabetes who are referred to and followed in the Vanderbilt Eskind
        Diabetes Clinic and are participants in the gestational diabetes educational program.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women with gestational diabetes who are referred to and followed in the Vanderbilt
             Eskind Diabetes Clinic and are participants in the gestational diabetes educational
             program.

        Exclusion Criteria:

          -  Refusal of consent.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Vanderbilt University : Vanderbilt Diabetes Center (VDC)</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37237-8148</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <lastchanged_date>July 20, 2011</lastchanged_date>
  <firstreceived_date>November 30, 2009</firstreceived_date>
  <responsible_party>
    <name_title>Tom A. Elasy, MD</name_title>
    <organization>Vanderbilt University Medical Center</organization>
  </responsible_party>
  <keyword>Gestational Diabetes</keyword>
  <keyword>Self-Monitoring of Blood Glucose</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
